Author: Multibagger News

AI Stocks: Goldman Sachs Analysts Encourage Investors to Buy the Dip Goldman Sachs analysts are advising investors to take advantage of the recent dip in AI stocks, stating that AI-related companies are still fundamentally strong. In a recent note titled “Buy the dip in AI,” the investment bank highlighted that their AI data centers basket (GSTMTDAT) and AI PC & mobile device upgrades basket (GSXUPCAI) have returned to benchmark levels, while the Broad AI basket (GSTMTAIP) is down 12% from its year-to-date highs. Despite the drop, these stocks have outperformed earnings expectations by an average of 8%, trading at a…

EU Antitrust Officials Target Google’s Adtech Practices: No Breakup Ordered Yet By Foo Yun Chee BRUSSELS (Multibagger) – In a significant development for the digital advertising landscape, EU antitrust officials are considering mandating Alphabet’s Google (NASDAQ: GOOG) to cease its anti-competitive practices within its adtech sector. Contrary to prior warnings, the European Union is not expected to order a breakup of Google’s adtech business at this stage, according to sources with direct knowledge of the situation. EU Antitrust Ruling on Google: What You Need to Know European Union regulators are poised to make a crucial decision in the upcoming months.…

Title: “Breaking News: U.S. Imposes Sanctions on Russian Entities for Destabilizing Countries – Analysis by Top Investment Manager and Financial Market Journalist” Washington (Multibagger) – In a significant move, the United States has announced sanctions on three entities and two individuals linked to a Russian campaign aimed at destabilizing countries globally, as revealed by U.S. Secretary of State Antony Blinken on Friday. During a press briefing at the State Department, Blinken highlighted the involvement of Russian broadcaster RT in this campaign, noting that it has expanded its operations beyond conventional media activities to include cyber capabilities. The Secretary of State…

Halozyme Therapeutics Receives FDA Approval for OCREVUS ZUNOVO™ – A Game Changer in MS Treatment | InvestingPro Insights SAN DIEGO – In a groundbreaking development, Halozyme Therapeutics, Inc. (NASDAQ: HALO) has secured FDA approval for OCREVUS ZUNOVO™, a revolutionary new formulation for treating multiple sclerosis (MS) in collaboration with Roche. This approval introduces a convenient subcutaneous injection option for patients with relapsing and primary progressive MS, administered twice a year. OCREVUS ZUNOVO™ leverages Halozyme’s innovative ENHANZE® drug delivery technology to provide a more user-friendly alternative to existing intravenous formulations. The FDA’s decision is backed by the Phase III OCARINA II…

Title: US Presidential Election and Economic Outlook to Drive Global Markets in Next 8 Weeks – Barclays Analysts Investing.com — Global markets are poised to closely monitor the US over the next eight weeks, with a focus on the upcoming US presidential election and the broader economic landscape, as highlighted by analysts at Barclays. The analysts emphasized the significant impact of the US election on global markets, stating that “as America goes, so goes the rest of the world” for the remainder of the year. The decision to elect a new president on Nov. 5 is expected to have far-reaching…

Ultimate Guide to Understanding Financial and Cryptocurrency Trading Risks Risk Warning: Protect Your Investments in Financial Instruments and Cryptocurrencies Key Takeaways: High Risk Involved: Trading financial instruments and cryptocurrencies can lead to partial or total loss of investment. Volatility: Cryptocurrency prices are highly volatile and influenced by external factors like financial, regulatory, or political events. Margin Trading: Increases financial risks significantly. Informed Decisions: Understand all risks and costs before trading. Seek professional advice if necessary. Data Accuracy: Prices on the website may not reflect real-time or accurate market prices. Comprehensive Risk Analysis for Financial and Cryptocurrency Trading Trading in financial…

President Biden Condemns False Claims About Haitian Immigrants in Ohio President Joe Biden spoke out against the false claims made by Republican candidate Donald Trump regarding the Haitian community in Ohio. During a White House event celebrating Black excellence, Biden highlighted the contributions of Haitian Americans and called for an end to the attacks on this community. Trump’s remarks about immigrants eating household pets have been debunked by city officials in Springfield, Ohio, where a large number of Haitian immigrants have recently settled. Despite the lack of evidence supporting these claims, Trump and his associates continue to spread misinformation about…

The Orwellian Legislation Threatening Bitcoin Holders in Australia: A Warning from Chief Crypto Analyst In a recent tweet, Jamie Coutts, chief crypto analyst at Real Vision, raised concerns over potential legislation in Australia that could make holding Bitcoin illegal. The legislation warns of “serious harm” to public confidence in certain aspects of public life, including the banking system. Coutts and journalist Alex James highlighted the implications of expressing a lack of confidence in the banking system, which could be classified as defamation. Bitcoin, created as an alternative to the banking system, faces scrutiny under this legislation. Coutts and James both…

Capnia Inc Stock Reaches 52-Week High at $53.85, Soleno Therapeutics Makes Strides with DCCR Treatment In a surprising turn of events, Capnia Inc stock has surged to a 52-week high of $53.85, marking a remarkable 1152.36% increase in value over the past year. This milestone showcases the company’s financial strength and positive investor sentiment. On the other hand, Soleno Therapeutics has made significant progress with its DCCR treatment for Prader-Willi Syndrome, receiving FDA acceptance for its New Drug Application. Analysts are bullish on Soleno, with price targets ranging from $59 to $70 per share. InvestingPro Insights reveal that Capnia Inc,…

Federal Reserve Meeting Preview: Will the Fed Cut Rates by 25 bps or 50 bps? As the Federal Reserve gears up for its next meeting, the big question on everyone’s mind is whether the central bank will opt for a more conservative 25 basis point (bps) interest rate cut or go all in with a bold 50 bps move. According to top analysts at Citi, the key factor that could sway the Fed’s decision is the upcoming retail sales report. In a recent note, Citi analysts laid out their predictions, forecasting a 25 bps rate cut followed by two more…